Foghorn Therapeutics Inc. (FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than ...

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $7.84, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Foghorn Therapeutics Inc. FHTX shares are trading lower by 8.49% to $4.85 during Monday’s session after the company announced it will discontinue independent development of its FHD-286 program ...

Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are neutral on FHTX stock.

Foghorn Therapeutics Inc. (FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than ...